Clinical Significance of NKD Inhibitor of WNT Signaling Pathway 1 (NKD1) in Glioblastoma

Figure 1

Expression difference of NKD1-mRNA in different glioma subtypes: (a) comparison of NKD1-mRNA level in different glioma histological subtypes, (b) comparison of NKD1-mRNA level in gliomas with different WHO grades, (c) comparison of NKD1-mRNA level in gliomas with wild type or mutated IDH, (d) comparison of NKD1-mRNA level in gliomas with 1p/19q codeletion or non-codeletion, and (e) comparison of NKD1-mRNA level in normal brain tissues and glioblastomas.

(a)

(b)

(c)

(d)

(e)